Viveve Medical (VIVE) is Initiated by Ladenburg Thalmann to Buy

Viveve Medical (VIVE) was Initiated by Ladenburg Thalmann to “Buy”. Ladenburg Thalmann advised their investors in a research report released on Sep 20, 2016.

In a different news, on Jun 21, 2016, Scott Durbin (CFO) purchased 1,500 shares at $5.00 per share price. According to the SEC, on Jun 21, 2016, Patricia Scheller (CEO) purchased 6,000 shares at $5.00 per share price. On Jun 21, 2016, James G. Atkinson (CBO & President) purchased 100,000 shares at $5.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Viveve Medical

Leave a Reply

Viveve Medical - Is it time to Sell?

Top Brokerage Firms are advising their investors on Viveve Medical. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.